Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Owsianka, Ania M.; Tarr, Alexander W.; Keck, Zhen Yong; Li, Ta Kai; Witteveldt, Jeroen; Adair, Richard; Foung, Steven K.H.; Ball, Jonathan K.; Patel, Arvind H.

Abstract

The humoral response to hepatitis C virus (HCV) may contribute to controlling infection. We previously isolated human monoclonal antibodies to conformational epitopes on the HCV E2 glycoprotein. Here, we report on their ability to inhibit infection by retroviral pseudoparticles incorporating a panel of full-length E1 E2 clones representing the full spectrum of genotypes 1-6. We identified one antibody, CBH-5, that was capable of neutralizing every genotype tested. It also potently inhibited chimeric cell culture-infectious HCV, which had genotype 2b envelope proteins in a genotype 2a (JFH-1) background. Analysis using a panel of alanine-substitution mutants of HCV E2 revealed that the epitope of CBH-5 includes amino acid residues that are required for binding of E2 to CD81, a cellular receptor essential for virus entry. This suggests that CBH-5 inhibits HCV infection by competing directly with CD81 for a binding site on E2. © 2008 SGM.

Citation

Owsianka, A. M., Tarr, A. W., Keck, Z. Y., Li, T. K., Witteveldt, J., Adair, R., Foung, S. K., Ball, J. K., & Patel, A. H. (2008). Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein. Journal of General Virology, 89(3), 653-659. https://doi.org/10.1099/vir.0.83386-0

• Journal Article Type: Article
• Acceptance Date: Nov 19, 2007
• Online Publication Date: Mar 1, 2008
• Publication Date: 2008
• Deposit Date: Nov 9, 2022
• Publicly Available Date: Nov 10, 2022
• Journal: Journal of General Virology
• Print ISSN: 0022-1317
• Publisher: Microbiology Society
• Peer Reviewed: Peer Reviewed
• Volume: 89
• Issue: 3
• Pages: 653-659
• DOI: https://doi.org/10.1099/vir.0.83386-0
• Public URL: https://nottingham-repository.worktribe.com/output/3129561